Biblography On Memory Loss

Alexander, G. E., Furey, M. L., Grady, C. L., Pietrini, P., Brady, D. R., Mentis, M. J., Schapiro, M. B. Association of premorbid intellectual function with cerebral metabolism in Alzheimer's disease: implications for the cognitive reserve hypothesis. American Journal of Psychiatry 154:165-172, 1997.

Alexopoulos, G. S., Meyers, B. S., Young, R. C., Mattis, S., Kakuma, T. The course of geriatric depression with "reversible dementia": a controlled study. American Journal of Psychiatry 150:1693-1699, 1993.

Amaducci, L., and the Smid group. Phosphatidylserine in the treatment of Alzheimer's disease: results of multicenter study. Psychopharmacology Bulletin 24:130-134, 1988.

Amaducci, L. A., Fratiglioni, L., Rocca, W. A., et al. Risk factors for clinically diagnosed Alzheimer's disease: a case-control study of Italian population. Neurology 36:922-931, 1986.

Anschutz, L., Camp, C., Markley, R., Kramer, J. Remembering mnemonics: A three-year follow-up on the effects of mnemonics training in elderly adults. Experimental Aging Research 13:141-143, 1987.

Argyriou, A., Prast, H., Philippu, A. Melatonin facilitates short-term memory. European Journal of Pharmacology 349:159-162, 1998.

Backman, L., Small, B. J. Influences of cognitive support on episodic remembering: tracing the process of loss from normal aging to Alzheimer's disease. Psychology and Aging 13:267-276, 1998.

Ball, M. J., Hachinski, V., Fox, A., et al. A new definition of Alzheimer's disease: a hippocampal dementia. Lancet 5:1416, 1985.

Barber, R., Scheltens, P., Gholkar, A., Ballard, C., McKeith, I., Ince, P., Perry, R., O'Brien, J. White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging. Journal of Neurology, Neurosurgery and Psychiatry 67:66-72, 1999.

Barona, A., Reynolds, C., Chastain, R. A demographically based index of permorbid intelligence for the WAIS-R. Journal of Consulting and Clinical Psychology 52:885 -887, 1984.

Bartzokis, G., Beckson, M., Hance, D. B., Po, H., Foster, J. A., Mintz, J., Ling, W., Bridge, P. Magnetic resonance imaging evidence of "silent" cerebrovascular toxicity in cocaine dependence. Biological Psychiatry 45:1203-1211, 1999.

Bechara, A., Tranel, D., Damasio, H., Adolphs, R., Rockland, C., Damasio, A. R. Double dissociation of conditioning and declarative knowledge relative to the amygdala and hippocampus in humans. Science 269:1115-1118, 1995.

Berg, L., McKeel, D. W., Miller, J. P., Storandt, M., Rubin, E. H., Morris, J. C., Baty, J., et al. Clinicopathologic studies in cognitively healthy aging and Alzheimer disease. Archives of Neurology 55:326-330, 1998.

Berr, C., Lafont, S., Debuire, B., Dartigues, J. F., Baulieu, E. E. Relationships of dehydroepiandrosterone sulfate (DHEA) in the elderly with functional, psychological and mental status, and short-term mortality: a French community-based study. Proceedings of the National Academy of Sciences, USA 93:13410-13415, 1996.

Block, R. I., Wittenborn, J. R. Marijuana effects on the speed of memory retrieval in the letter-matching task. International Journal of the Addictions 21:281-285, 1986.

Bowen, J. D., Larson, E. B. Drug-induced cognitive impairment: defining the problem and finding solutions. Drugs and Aging 3:349-357, 1993.

Buschke, H., Fuld, P. A. Evaluating storage, retention, and retrieval in disordered memory and learning. Neurology 24:1019-1025, 1974.

Buschke, H., Kuslansky, G., Katz, M., Stewart, W. F., Silwinski, M. J., Eckholdt, H. M., Lipton, R. B. Screening for dementia with the memory impairment screen. Neurology 52:231-238, 1999.

Caffarra, P., Santamaria, V. The effects of phosphatidylserine in patients with mild cognitive decline. Clinical Trials Journal 24:109-114, 1987.

Cassone, M. C., Molinengo, L. Action of thyroid hormones, diazepam, caffeine, and amitriptyline on memory decay ("forgetting"). Life Sciences 29:1983-1988, 1981.

Cavanaugh, J. C., Grady, J. G., Perlmutter, M. Forgetting and use of memory aids in 20- to 70-year olds' everyday life. International Journal of Aging and Human Development 17:113-122, 1983.

Chandra, V., Kokmen, E., Schoenberg, B. S., Beard, C. M. Head trauma with loss of consciousness as a risk factor for Alzheimer's disease. Neurology 39:1576-1578, 1989.

Choi, D. W., Koh, J. Y. Zinc and brain injury. Annual Review of Neuroscience 21:347-375, 1998.

Christensen, H., Korten, A., Jorm, A. F., Henderson, A. S., Scott, R., MacKinnon, A. J. Activity levels and cognitive functioning in an elderly community sample. Age and Aging 25:72-80, 1996.

Christianson, S. A., Loftus, E. F. Memory for traumatic events. Applied Cognitive Psychology 1:225-233, 1987.

Claus, J. J., van Harskamp, F., Breteler, M. M. B., Krenning, E. P., de Koning, I., van der Cammen, T. J. M., Hofman, A., et al. The diagnostic value of SPECT with Tc 99m HMPAO in Alzheimer's disease: a population-based study. Neurology 44:454-461, 1994.

Coria, F., Gomez de Caso, J. A., Minguez, L., Rodriguez-Artalejo, F., Claveria, L. E. Prevalence of age-associated memory impairment and dementia in a rural community. Journal of Neurology, Neurosurgery and Psychiatry 56:973976, 1993.

Corkin, S. Functional MRI for studying episodic memory in aging and Alzheimer's disease. Geriatrics 53(Suppl 1):S13-15, 1998.

Costa, M. M., Reus, V. I., Wolkowitz, O. M., Manfredi, F., Lieberman, M. Estrogen replacement therapy and cognitive decline in memory-impaired post-menopausal women. Biological Psychiatry 46:182-188, 1999.

Cowley, C., Underwood, A. Memory. Newsweek, pages 49-52. June 15, 1998.

Crook, T. H., Adderley, B. The Memory Cure. Pocket Books, New York, 1998.

Crook, T. H., Tinklenberg, J., Yesavage, J., Petrie, W., Nunzi, M. G., Massari, D. C. Effects of phosphatidylserine in age-associated memory impairment. Neurology 41:644-649, 1991.

Damasio, A. R. Consciousness. Knowing how, knowing where. Nature 375:106-107, 1995.

Damasio, H., Grabowski, T. J., Tranel, D., Hichwa, R. D., Damasio, A. R. A neural basis for lexical retrieval. Nature 380:499-505, 1996.

Davies, G., Alonso-Quecuty, M. Cultural factors in the recall of a witnessed event. Memory 5:601-614, 1997.

de la Monte, S. M., Ghanbari, K., Frey, W. H., Beheshti, I., Averback, P., Hauser, S. L., Ghanbari, H. A., et al. Characterization of the AD7C-NTP cDNA expression in Alzheimer's disease and measurement of a 41 -kD protein in cerebrospinal fluid. Journal of Clinical Investigation 100:3093-3104, 1997.

de Leon, M. J., Convit, A., DeSanti, S., Bobinski, M., George, A. E., Wisniewski, H. M., Rusinek, H., et al. Contribution of structural neuroimaging to the early diagnosis of Alzheimer's disease. International Psychogeriatrics 9:183-190, 1997.

Devanand, D. P., Folz, M., Gorlyn, M., Moeller, J. R., Stern, Y. Questionable dementia: course and predictors of outcome. Journal of the American Geriatric Society 45:321 -328, 1997.

Devanand, D. P., Sano, M., Tang, M. X., Taylor, S., Gurland, B. J., Wilder, D., Stern, Y., et al. Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community. Archives of General Psychiatry 53:175-182, 1996.

Devanand, D. P., Michaels-Marston, K. S., Liu, X., Pelton, G. H., Padilla, M., Marder, K., Bell, K., Stern, Y., Mayeux, R. Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up. American Journal of Psychiatry 157:1399-1405, 2000.

DeWeer, B., Lehericy, S., Pillon, B., Baulac, M., Chiras, J., Marsault, C., Agid, Y., et al. Memory disorders in probable Alzheimer's disease: the role of hippocampal atrophy as shown with MRI. Journal of Neurology, Neurosurgery and Psychiatry 58:590-597, 1995.

Di Luca, M., Pastorino, L., Bianchetti, A., Perez, J., Vignolo, L. A., Lenzi, G. L., Trabucchi, M., Cattabeni, F., Padovani, A. Differential level of platelet amyloid beta precursor protein isoforms: an early marker for Alzheimer disease. Archives of Neurology 55:1195-2000, 1998.

Doraiswamy, P. M., Steffens, D. C. Combination therapy for Alzheimer's disease: what are we waiting for? Journal of the American Geriatrics Society 46:1322-1324, 1998.

Doty, R. L., Reyes, P. F., Gregor, T. Presence of both odor identification and detection deficits in Alzheimer's disease. Brain Research Bulletin 18:597-600, 1987.

Enns, M., Peeling, J., Sutherland, G. R. Hippocampal nerve cells are damaged by caffeine-augmented electroshock seizures. Biological Psychiatry 40:642-647, 1996.

Erber, J. T., Szuchman, L. T., Rothberg, S. T. Dimensions of self-report about everyday memory in young and older adults. International Journal of Aging and Human Development 34:311 -323, 1992.

Evans, D. A., Hebert, L. E., Beckett, L. A., Scherr, P. A., Albert, M. S., Chown, M. J., Pilgrim, D. M., et al. Education and other measures of socioeconomic status and risk of incident Alzheimer disease in a defined population of older persons. Archives of Neurology 54:1399-1405, 1997.

Farlow, M., Gracon, S. I., Hershey, L. A., Lewis, K. W., Sadowsky, C. H., Dolan-Ureno, J., for the Tacrine Study Group. Journal of the American Medical Association 268:2523-2529, 1992.

Fiatarone, M. A., O'Neill, E. F., Ryan, N. D., Clements, K. M., Solares, G. R., Nelson, M. E., Roberts, S. B., Kehayias, J. J., Lipsitz, L. A., Evans, W. J. Exercise training and nutritional supplementation for physical frailty in very elderly people. New England Journal of Medicine 330:17691775, 1994.

FitzSimon, J. S., Waring, S. C., Kokmen, E., McLaren, J. W., Brubaker, R. F. Response of the pupil to tropicamide is not a reliable test for Alzheimer disease. Archives of Neurology 54:155-159, 1997.

Folstein, M., Folstein, S., McHugh, P. "Mini-mental state": a practical method of grading the cognitive state of patients for clinicians. Journal of Psychiatric Research 12:189-198, 1975.

Forbes, W. F., Lessard, S., Gentleman, J. F. Geochemical risk factors for mental functioning, based on the Ontario longitudinal study of aging (LSA) V. comparisons of the results, relevant to aluminium water concentrations, obtained from the LSA and from death certificates mentioning dementia. Canadian Journal on Aging 14:642-646, 1995.

Foster, R. G. Shedding light on the biological clock. Neuron 20:829-832, 1998.

Fox, N. C., Warrington, E. K., Seiffer, A. L., Agnew, S. K., Rossor, M. N. Presymptomatic cognitive deficits in individuals at risk of familial Alzheimer's disease. A longitudinal prospective study. Brain 121:1631-1639, 1998.

Fuld, P. A., Masur, D. M., Blau, A. D., Crystal, H., Aronson, M. K. Object-memory evaluation for prospective detection of dementia in normal functioning elderly: predictive and normative data. Journal of Clinical and Experimental Neuropsychology 12:520-528, 1990.

Gagnon, M., Letenneur, L., Dartigues, J. F., Commenges, D., Orgogozo, J. M., Gateau, P. B., Alperovitch, A., et al. Validity of the mini -mental state examination as a screening instrument for cognitive impairment and dementia in French elderly community residents. Neuroepidemiology 9:143-150, 1990.

Galasko, D., Clark, C., Chang, L., Miller, B., et al. Assessment of CSF levels of tau protein in mildly demented patients with Alzheimer's disease. Neurology 48:632-635, 1997.

Gao, S., Hendrie, H. C., Hall, K. S., Hui, S. The relationships between age, sex, and the incidence of dementia and Alzheimer disease: a meta-analysis. Archives ofGeneral Psychiatry 55:809-815, 1998.

Ghanbari, H., Ghanbari, K., Beheshti, I., Munzar, M., Vasauskas, A., Averback, P. Biochemical assay for AD7C-NTP in urine as an Alzheimer's disease marker. Journal of Clinical and Laboratory Analysis 12:285-288, 1998.

Gilewski, M. J., Zelinski, E. M., Schaie, K. W. The Memory Functioning Questionnaire for the assessment of memory complaints in adulthood and old age. Psychology and Aging 5:482-490, 1990.

Giovagnoli, A. R., Mascheroni, S., Avanzini, G. Self-reporting of everyday memory in patients with epilepsy: relation to neuropsychological, clinical, pathological and treatment factors. Epilepsy Research 28:119 -128, 1997.

Golomb, J., Kluger, A., de Leon, M. J., Ferris, S. H., Mittelman, M., Cohen, J., George, A. E. Hippocampal formation size predicts declining memory performance in normal aging. Neurology 47:810-813, 1996.

Gould, E. C., Woolley, C. S., McEwen, B. S. The hippocampal formation: morphological changes induced by thyroid, gonadal, and adrenal hormones. Psychoneuroendocrinology 16:67-84, 1991.

Gower, T. Is there a magic memory bullet? Esquire, page 142, December 1997.

Grant, S., London, E., Newlin, D. B., Villemagne, V. L., Liu, X., Contoreggi, C., Phillips, R. L., Kimes, A. S., Margolin, A. Activation of memory circuits during cue-elicited cocaine craving. Proceedings of the National Academy of Sciences 93:12040-12045, 1996.

Greenwood, C. E., Winocur, G. Learning and memory impairment in rats fed a high saturated fat diet. Behavioral Neurology and Biology 53:74-87, 1990.

Growdon, J. H., Graefe, K., Tenis, M., Hayden, D., Schoenfeld, D., Wray, S. H. Pupil dilation to tropicamide is not specific for Alzheimer disease. Archives of Neurology 54:841 -844, 1997.

Hall, S. S. Our memories, our selves. New York Times Sunday Magazine, pages 26-33, 49-57. February 15, 1998.

Hanninen, M. A., Hallikainen, M., Koivisto, K., et al. A follow-up study of age-associated memory impairment: neuropsychological predictors of dementia. Journal of the American Geriatric Society 43:1007-1015, 1995.

Hassing, L., Wahlin, A., Winblad, B., Backman, L. Further evidence on the effects of vitamin B12 and folate levels on episodic memory functioning: a population-based study of healthy very old adults. Biological Psychiatry 45:14721480, 1999.

Hayaishi, O. Tryptophan, oxygen, and sleep. Annual Review of Biochemistry 63:1-24, 1994.

Heishman, S. J., Arasteh, K., Stitzer, M. L. Comparative effects of alcohol and marijuana on mood, memory, and performance. Pharmacology and Biochemistry of Behavior 58:93-101, 1997.

Hendler, N., Cimini, C., Ma, T., Long, D. A comparison of cognitive impairment due to benzodiazepines and to narcotics. American Journal of Psychiatry 137:828-830, 1980.

Heseker, H., Schneider, R. Requirement and supply of vitamin C, E and beta-carotene for elderly men and women. European Journal of Clinical Nutrition 48:118-127, 1994.

Heyman, A., Fillenbaum, G. G., Welsh-Bohmer, K. A., Gearing, M., Mirra, S. S., Mohs, R. C., Peterson, R. L., Pieper, C. F. Cerebral infarcts with autopsy-proven Alzheimer's disease: CERAD, part XVIII. Consortium to Establish a Registry for Alzheimer's Disease. Neurology 51:159-162, 1998.

Higbee, K. L. Your Memory: How It Works and How to Improve It, Second edition. Paragon House, New York, 1988.

Hyman, S. T., Gomaz-Isla, T., Briggs, M., Chung, H., Nichols, S., Kohout, F., Wallace, R. Apolipoprotein E and cognitive change in an elderly population. Annals of Neurology 40:55-66, 1996.

Israel, L., Melac, M., Milinkevitch, D., Dubos, G. Drug therapy and memory training programs: a double-blind randomized trial of general practice patients with age -associated memory impairment. International Psychogeriatrics 6:155-170, 1994.

Jabs, T. Reactive oxygen intermediates as mediators of programmed cell death in plants and animals. Biochemical Pharmacology 57:231-245, 1999.

Jack, C. R. Jr., Petersen, R. C., Xu, Y., O'Brien, P. C., Smith, G. E., Ivnik, R. J., Tangalos, E. G., Kokmen, E. Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease, Neurology 51:993 -999, 1998.

Jacobs, D. M., Sano, M., Dooneief, G., Marder, K., Bell, K. L., Stern, Y., Neuropsychological detection and characterization of preclinical Alzheimer's disease. Neurology 45:957-962, 1995.

Jacobsen F.M., Comas-Diaz L. Donepezil for psychotropic-induced memory loss. Journal of Clinical Psychiatry 60:698704, 1999.

Jama, J. W., Launer, L. J., Witteman, J. C., den Breeijen, J. H., Breteler, M. M., Grobbee, D. E., Hofman, A. Dietary antioxidants and cognitive function in a population-based sample of older persons. The Rotterdam study. American Journal of Epidemiology 144:275-280, 1996.

Jazwinski, M. J. Longevity, genes, and aging. Science 273:54-58, 1996.

Jimenez-Jimenez, F.J., Molina, J. A., de Bustos, F., Orti-Pareja, M., Benito-Leon, J., Tallon-Barranco, A., Gasalla, T., Porta, J., Arenas, J. Serum levels of beta-carotene, alpha-carotene and vitamin A in patients with Alzheimer's disease. European Journal of Neurology 6:495-497, 1999.

Johansson, B., Zarit, S. H. Early cognitive markers of the incidence of dementia and mortality: a longitudinal population -based study of the oldest old. International Journal of Geriatric Psychiatry 12:53-59, 1997.

Jonker, C., Launer, L. J., Hooijer, C., Lindeboom, J. Memory complaints and memory impairment in older individuals. Journal of the American Geriatrics Society 44:44-49, 1996.

Kandel, E. R. Genes, synapses, and long-term memory. Journal ofCell Physiology 173:124-125, 1997.

Kandel, E. R., Abel, T. Neuropeptides, adenyl cyclase, and memory storage. Science 268:825-826, 1995.

Kawas, C. S., Resnick, S., Morrison, A., Brookmeyer, R., Corrada, M., Zonderman, A., Bacal, C., Lingle, D. D., Metter, E. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore longitudinal study of aging. Neurology 48:1517-1521, 1997.

Keller, M. B., McCullough, J. P., Klein, D. N., Arnow, B., Dunner, D. L., Gelenberg, A. J., Markowitz, J. C., Nemeroff, C. B., Russell, J. M., Thase, M. E., Trivedi, M. H., Zajecka, J. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. New England Journal of Medicine 342:1462-1470, 2000.

Kliegl, R., Smith, J., Baltes, P. B. Testing-the-limits and the study of adult age differences in cognitive plasticity of a mnemonic skill. Developmental Psychology 25:247-256, 1989.

Koivisto, K., Reinikainen, K. J., Vanhanen, M., Helkala, E., Mykkannen, L., Laakso, M., Pyorala, K., et al. Prevalence of age-associated memory impairment in a randomly selected population from eastern Finland. Neurology 45:741 -747, 1995.

Kral, V. A. Senescent forgetfulness, benign and malignant. Canadian Medical Association Journal 86:257-260, 1962.

Kramer, A. F., Hahn, S., Cohen, N. J., Banich, M. T., McAuley, E., Harrison, C. R., Chason, J., Vakil, E., Bardell, L., Boileau, R. A., Colcombe, A. Ageing, fitness and neurocognitive function. Nature 400:418-419, 1999.

Lang, F. R., Carstensen, L. L. Close emotional relationships in late life: further support for proactive aging in the social domain. Psychological Aging 9:315-324, 1994.

Launer, L. J., Masaki, K., Petrovitch, H., Foley, D., Havlik, R. J. The association between midlife blood pressure levels and late-life cognitive function. The Honolulu Asia aging study. Journal of the American Medical Association 274:1846-1851, 1995.

Le Bars, P. L., Katz, M. M., Berman, N., Itil, T. M., Freedman, A. M., Schatzberg, A. F. A placebo-controlled, double-blind, randomized trial of an extract of ginkgo biloba for dementia. Journal of the American Medical Association 278:1327-1332, 1997.

Lemonick, M. D. Beyond depression. What do these "mood drugs'' really do? Time 153:74, May 17, 1999.

Leo, M. A., Lieber, C. S. Alcohol, vitamin A, and beta-carotene: adverse interactions, including hepatotoxicity and carcinogenicity. American Journal of Clinical Nutrition 69:1071-1085, 1999.

Letzel, H., Haan, J., Feil, W. B. Nootropics: efficacy and tolerability of products from three active substance classes. Journal of Drug Decision in Clinical Practice 8:77-94, 1996.

Lipsky, P. E. The clinical potential of cyclooxygenase-2 inhibitors. American Journal of Medicine 106 (5B):51S-57S, 1999.

Lissner, L., Bengtsson, C., Bjorkelund, C., Wedel, H. Physical activity levels and changes in relation to longevity. A prospective study of Swedish women. American Journal of Epidemiology 143:54-62, 1996.

Loke, W. H. Effects of caffeine on mood and memory. Physiology and Behavior 44:367 -372, 1988.

Lucca, U., Tettamanti, M., Forloni, G., Spagnoli, A. Nonsteroidal anti-inflammatory drug use in Alzheimer's disease. Biological Psychiatry 36:854-856, 1994.

Lund-Manchester Group. Clinical and neuropathological criteria for frontotemporal dementia. Journal of Neurology, Neurosurgery and Psychiatry 57:416-418, 1994.

Martzke, J. S., Kopala, L. C., Good, K. C. Olfactory disfunction in neuropsychiatric disorders: review and methodological considerations. Biological Psychiatry 42:721-732, 1997.

Marwick, C. Growing use of medicinal botanicals forces assessment by drug regulators. Journal of the American Medical Association 273:607-609, 1995.

Masuda, Y., Kokubu, T., Yamashita, M., Ikeda, H., Inoue, S. Egg phosphatidylcholine combined with vitamin B12 improved memory impairment following lesioning of nucleus basalis in rats. Life Sciences 62:813-822, 1998.

Matthews, M. K. Association of ginkgo biloba with intracerebral hemorrhage. Neurology (letter) 50:1933-1934, 1998.

Mayeux, R., Saunders, A. M., Shea, S., Mirra, S., Evans, D., Roses, A., Hyman, B., et al. Utility of the apolipoprotein e genotype in the diagnosis of Alzheimer's disease. New England Journal of Medicine 338:506-511, 1998.

Maylor, E. A., Rabbitt, P. M. Effect of alcohol on rate of forgetting. Psychopharmacology (Berlin) 91:230-235, 1987.

McCleary, R., Dick, M. B., Buckwalter, G., Henderson, V. Full-information models for multiple psychometric tests: annualized rates of change in normal aging and dementia. Alzheimer Disease and Associated Disorders 10:216-223, 1996.

McEwen, B. S. Permanence of brain sex differences and structural plasticity of the adult brain. Proceedings of the National Academy of Sciences 96:7128-7130, 1999.

-Protective and damaging effects of stress mediators. New England Journal of Medicine 338:171-179, 1998.

-Stress and hippocampal plasticity. Annual Review of Neuroscience 22:105-122, 1999.

McEwen, B. S., Alves, S. E. Estrogen actions in the central nervous system. Endocrinology Review 20:279-307, 1999.

McGeer, P. L., Schulzer, M., McGeer, E. G. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology 47:425-432, 1996.

McKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L, A., Salmon, D. P., et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47:1113-1124, 1996.

Means, L. W., Higgins, J. L., Fernandez, T. J. Mid-life onset of dietary restriction extends life and prolongs cognitive functioning. Physiology and Behavior 54:503-508, 1993.

Meier, B. Industry's next growth sector: memory lapses. New York Times, pages 1, 17, April 4, 1999.

Mendelsohn, A. B., Belle, S. H., Stoehr, G. P., Ganguli, M. Use of antioxidant supplements and its association with cognitive function in a rural elderly cohort: the MoVIES project. Monongahela Valley Independent Elders Survey. American Journal of Epidemiology 148:38-44, 1998.

Miller, G. A. The magical number seven: plus or minus two. Some limits on our capacity for processing information. Psychological Review 9:81-97, 1956.

Mohs, R. C., Ashman, T. A., Jantzen, K., Albert, M., Brandt, J., Gordon, B., Rasmusson, X., Grossman, M., Jacobs, D., Stern, Y. A study of the efficacy of a comprehensive memory enhancement program in healthy elderly persons. Psychiatry Research 77:183-195, 1998.

Morris J. C., Storandt, M., McKeel, D. W., Rubin, E. H., Price, J. L., Grant, E. A., Berg, L. Cerebral amyloid deposition and diffuse plaques in "normal" aging: evidence for presymptomatic and very mild Alzheimer's disease. Neurology 46:707-719, 1996.

Mulnard, R. A., Cotman, C. W., Kawas, C., van Dyck, C. H., Sano, M., Doody, R., Koss, E., Pfeiffer, E., Jin, S., Gamst, A., Grundman, M., Thomas, R., Thal, L. J. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study. Journal of the American Medical Association 283:1007-15, 2000.

Newcomer, J. W., Selke, G., Melson, A. K., Hershey, T., Craft, S., Richards, K, Alderson, A. L. Decreased memory performance in healthy humans induced by stress-level cortisol treatment. Archives of General Psychiatry 56:527-533, 1999.

Newman, P. E. Could diet be used to reduce the risk of Alzheimer's disease? Medical Hypotheses 50:335-337, 1998.

Nordin, S., Murphy, C. Odor memory in normal aging and Alzheimer's disease. Annals of the New York Academy of Sciences 855:686-693, 1998.

Oken, B. S., Storzbach, D. M., Kaye, J. A. The efficacy of ginkgo biloba on cognitive function in Alzheimer disease. Archives of Neurology 55:1409-1415, 1998.

Orentreich, N., Brind, J. L. Long-term longitudinal measurements of plasma dehydroepiandrosterone sulfate in normal men. Journal of Clinical Endocrinology and Metabolism 75:1002-1004, 1992.

Osterweil, D., Syndulko, K., Cohen, N., Pettler-Jennings, P. D., Hershman, J. M., Cummings, J. L., Tourtellotte, W. W., Solomon, D. H. Cognitive function in non-demented older adults with hypothyroidism. Journal of the American Geriatric Society 40:325-335, 1992.

Perrig, W. J., Perrig, P., Stahelin, H. B. The relation between antioxidants and memory performance in the old and very old. Journal of the American Geriatrics Society 45:718-724, 1997.

Petersen, R. C. Normal aging, mild cognitive impairment, and early Alzheimer's disease. The Neurologist 1:326-344, 1995.

Peterson, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., Kokmen, E. Mild cognitive impairment: clinical characterization and outcome. Archives of Neurology 56:303-308, 1999.

Plassman, B. L., Welsh, K. A., Helms, M., Brandt, J., Page, W. F., Breitner, J. C. Intelligence and education as predictors of cognitive state in late life: a 50-year follow-up. Neurology 45:1446-1450, 1995.

Rai, G. S., Shovlin, C., Wesnes, K. A. A double-blind placebo-controlled study of ginkgo biloba extract ("Tanakan") in elderly outpatients with mild to moderate memory impairment. Current Medical Research Opinion 12:350-355, 1991.

Reid, L. D., Johnson, R. E., Gettman, D. A. Benzodiazepine exposure and functional status in older people. Journal oj the American Geriatric Society 46:71-76, 1998.

Reisberg, B., Ferris, S. H., Anand, R., Mir, P., Geibel, V., De Leon, M. J. Effects of naloxone in senile dementia: a double-blind trial. New England Journal of Medicine 308:721-722, 1983.

Reisberg, B., Ferris, S. H., Franssen, E., Kluger, A., Borenstein, J. Age-associated memory impairment: the clinical syndrome. Developmental Neuropsychology 2:401-412, 1986.

Rogers, S. L., Farlow, M. R., Doody, R. S., Mohs, R., Friedhoff, L. T., and the Donepezil study group. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Neurology 50:136-145, 1998.

Rosler, M., Anand, R., Cicin-Sain, A., Gauthier, S., Agid, Y., Dal-Bianco, P., Stahelin, H. B., Hartman, R., Gharabawi, M. Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial. British Medical Journal 318(7184):633 -638, 1999.

Ryabinin, A. E. Role of hippocampus in alcohol-induced memory impairment: implications from behavioral and early gene studies. Psychopharmacology 139:34-43, 1998.

Sackeim, H. A., Steif, B. L. The neuropsychology of depression and mania. In: Georgotas, A., Cancro, R., eds. Depression and Mania. New York: Elsevier, 1988:265-289.

Sano, M., Ernesto, C., Thomas, R. G., Klauber, M. R. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. New England Journal of Medicine 336:1216-1222, 1997.

Sapolsky, R. M., Krey, L. C., McEwen, B. S. The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocrinology Review 7:284-301, 1986.

Satoh, T., Sakurai, I., Miyagi, K., Hohsaku, Y. Walking exercise and improved neuropsychological functioning in elderly patients with cardiac disease. Journal of Internal Medicine 238:423-428, 1995.

Schacter, D. L. Searching for memory: the brain, the mind, and the past. Basic Books, New York, 1996.

Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., Kholodenko, D., Lee, M., Liao, Z., Lieberburg, I., Motter, R., Mutter, L., Soriano, F., Shopp, G., Vasquez, N., Vandevert, C., Walker, S., Wogulis, M., Yednock, T., Games, D., Seubert, P. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400:173-177, 1999.

Schmand, B., Jonker, C., Hooijer, C., Lindeboom, J. Subjective memory complaints may announce dementia. Neurology 46:121-125, 1996.

Scogin, F., Bienias, J. A three-year follow-up of older adult participants in a memory skills training program. Psychology and Aging 3:334-337, 1988.

Shapiro, S. L., Schwartz, G. E., Bonner, G. Effects of mindfulness-based stress reduction on medical and premedical students. Journal of Behavioral Medicine 21:581-599, 1998.

Slaven, L., Lee, C. Mood and symptom reporting among middle-aged women: the relationship between menopausal status, hormone replacement therapy, and exercise participation. Health Psychology 16:203-208, 1997.

Slotten, H. A., Krekling, S. Does melatonin have an effect on cognitive performance? Psychoneuroendocrinology 21:673-680, 1996.

Small, G. W., La Rue, A., Komo, S., Kaplan, A., Mandelkern, M. A. Predictors of cognitive change in middle-aged and older adults with memory loss. American Journal of Psychiatry 152:1757-1764, 1995.

Snowdon, D. A., Griener, L. H., Mortimer, J. A., Riley, K. P., Greiner, P. A., Markesbery, W. R. Brain infarction and the clinical expression of Alzheimer's disease: the nun study. Journal of the American Medical Association 277:813-817, 1997.

Snowdon, D. A., Kemper, S.J., Mortimer, J. A., Greiner, L. H., Wekstein, D. R., Markesbery, W. R. Linguistic ability in early life and cognitive function and Alzheimer's disease in late life. Findings from the nuns study. Journal of the American Medical Association 275:528-532, 1996.

Socci, D.J., Crandall, B. M., Arendash, G. W. Chronic antioxidant treatment improves the cognitive performance of aged rats. Brain Research 693:88-94, 1995.

Solfrizzi, V., Panza, F., Torres, F., Mastroianni, F., Del Parigi, A., Venezia, A., Capurso, A. High monounsaturated fatty acids intake protects against age -related cognitive decline. Neurology 52:1563-1569, 1999.

Solomon, P. R., Hirschoff, A., Kelly, B., Relin, M., Brush, M., DeVeaux, R. D., Pendlebury, W. W. A 7-minute neurocognitive screening battery highly sensitive to Alzheimer's disease. Archives of Neurology 55:349-355, 1998.

Stern, Y, Gurland, B., Tatemichi, T. K., Tang, M. X., Wilder, D., Mayeux, R. Influence of education and occupation on the incidence of Alzheimer's disease. Journal of the American Medical Association 271:1004-1010, 1994.

Stern, Y., Sano, M., Mayeux, R. Long-term administration of oral physostigmine in Alzheimer's disease. Neurology 38:1837-1841, 1988.

Stoll, S., Hafner, U., Pohl, W. E., Muller, W. E. Age-related memory decline and longevity under treatment with selegiline. Life Sciences 55:2155-2163, 1994.

Suhr, J., Tranel, D., Wefel, J., Barrash, J. Memory performance after head injury: contributions of malingering, litigation status, psychological factors, and medication use. Journal of Clinical and Experimental Neuropsychology 19:500-514, 1997.

Summers, W. K., Majovski, L. V., Marsh, G. M., Tachiki, K., Kling, A. Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type. New England Journal of Medicine 315:1241-1245, 1986.

Sunderland, A., Stewart, F. M., Sluman, S. M. Adaptation to cognitive deficit? An exploration of apparent dissociations between everyday memory and test performance late after stroke. British Journal of Clinical Psychology 35:463-476, 1996.

Tang, M. X., Jacobs, D., Stern, Y., Marder, K., Schofield, P., Gurland, B., Andrews, H., Mayeux, R. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 348:429-432, 1996.

Tariot, P. N., Solomon, P. R., Morris, J. C., Kershaw, P., Lilienfeld, S., Ding, C. A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group. Neurology 54:2269-2276, 2000.

Thal, L.J., Carta, A., Clarke, W. R., Ferris, S. H., Friedland, R. P., Peterson, R. C., Pettegrew, J. W., Pfeiffer, E., Raskind, M. A., Sano, M., Tuszynski, M. H., Woolson, R. F. A 1-year multicenter placebo-controlled study of acctyl -l-carnitine in patients with Alzheimer's disease. Neurology 47:705 -711, 1996.

Tierney, M. C., Szalai. J. P., Snow, W. G., Fisher, R. H., Tsuda, T., Chi, H., McLachlan, D. R., St. George-Hyslop, P. H. A prospective study of the clinical utility of ApoE genotype in the prediction of outcome in patients with memory impairment. Neurology 46:149-154, 1996.

Tierney, M. C., Szalai, J. P., Snow, W. G., Fisher, R. H., Nores, A., Nadon, G., Dunn, E., et al. Prediction of probable Alzheimer's disease in memory-impaired patients: a prospective longitudinal study. Neurology 46:661-665, 1996.

Tracy, J. I., Bates, M. E. The selective effects of alcohol on automatic and effortful memory processes. Neuropsychology 13:282-290, 1999.

Trojanowski, J. Q., Growdon, J. H. A new consensus report on biomarkers for the carly antemortem diagnosis of Alzheimer disease: current status, relevance to drug discovery, and recommendations for future research (editorial). Journal of Neuropathology and Experimental Neurology 57:643 -644, 1998.

Tune, L., Carr, S., Hoag, E., Cooper, T. Anticholinergic effects of drugs commonly prescribed for the elderly: potential means for assessing risk of delirium. American Journal of Psychiatry 149:1393-1394, 1992.

Van Ginj J., Low doses of aspirin in stroke prevention. Lancet 353:2172-2173, 1999.

Van Gorp, W. G., Wilkins, J. N., Moore, L. H., Hull, J., Horner, M. D., Plotkin, D. Declarative and procedural memory functioning in abstinent cocaine abusers. Archives of General Psychiatry 56:85-89, 1999.

Van Ryn, J., Pairet, M. Clinical experience with cyclooxygenase-2 inhibitors. Inflammation Research 48:247-254, 1999.

Verhaeghen, P., Marcoen,A., Goossens, L. Facts and fiction about memory aging: a quantitative integration of research findings. Journal of Gerontology 48:157-171, 1993.

Vernon, M. W., Sorkin, E. M. Piracetam. An overview of its pharmacological properties and a review of its therapeutic use in senile cognitive disorders. Drugs and Aging 1:17-35, 1991.

Warburton, D. M. Effects of caffeine on cognition and mood without caffeine abstinence. Psychopharmacology (Berlin) 119:66-70, 1995.

Watkins, P. B., Zimmerman, H.J., Knapp, M. J., Gracon, S. I., Lewis, K. W. Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease. Journal of the American Medical Association 271:992-998, 1994.

West, R. L., Crook, T. H., Barron, K. L. Everyday memory performance across the life span: effects of age and noncognitive individual diffrences. Psychology and Aging 7:72-82, 1992.

Wolf, O. T., Neumann, O., Hellhammer, D. H., Geiben, A. C., Strassburger, C. J., Dressendorfer, R. A., et al. Effects of a two-week physiological DHEA substitution on cognitive performance and well -being in healthy elderly women and men. Journal of Endocrinological Investigation 82:2363-2367, 1997.

Woodle, E. S., Kulkarni, S. Programmed cell death. Transplantation 66:681-691, 1998.

Yaffe, K., Ettinger, B., Pressman, A., Seeley, D., Whooley, M., Schaefer, C., Cummings, S. Neuropsychiatry function and dehydroepiandrosterone sulfate in elderly women: a prospective study. Biological Psychiatry 43:694-700, 1998.

Yaffe, K., Sawaya, G., Lieberburg, I., Grady, D. Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. Journal of the American Medical Association 279:688-695, 1998.

Young, E. A. DHEA: Mood, memory, and aging. Biological Psychiatry 45:1531-1532, 1999.

Zola-Morgan, S. M., Squire, L. R. The primate hippocampal formation: evidence for a time-limited role in memory storage. Science 250:288-290, 1990.

This page intentionally left blank

Super Serenity Sleepers

Super Serenity Sleepers

Do You Have Problem Getting A Good Night Sleep? Learn To Sleep Like A Cat At Night And Run Like A Lion When You Wake Up.

Get My Free Ebook


Post a comment